학술논문
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Document Type
Article
Author
Source
In Clinica e Investigacion en Arteriosclerosis November-December 2023 35(6):263-271
Subject
Language
ISSN
0214-9168